NCT04833517View on ClinicalTrials.gov

Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Prostate Cancer MetastaticCastration Resistant Prostatic CancerAdvanced Prostate Carcinoma
Trial Locations (1)

66421

RECRUITING

Dept. of Nuclear Medicine, Saarland University, Homburg

All Listed Sponsors
lead

Universität des Saarlandes

OTHER

NCT04833517 - Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study) | Biotech Hunter | Biotech Hunter